scholarly journals The Clinical Impact of Echocardiography on Patients in Tertiary Centres in South Africa

2018 ◽  
Vol 2 (2) ◽  
Keyword(s):  
South Africa ◽  
Cardiovascular Disease ◽  
Heart Disease ◽  
Cardiovascular Diseases ◽  
Cause Of Death ◽  
Clinical Impact ◽  
Direct Result

Globally cardiovascular disease, commonly referred to as heart disease or stroke, is the number 1 cause of death with one in three deaths being as a direct result of cardiovascular diseases ,claiming nearly 17.7million lives every year [1].

Sex-related trends of cardiovascular risk perception and prevention behaviors: results from the italian society of cardiovascular survey

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
A Polimeni ◽  
S Sorrentino ◽  
P Crea ◽  
C Spaccarotella ◽  
A Mongiardo ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Heart Disease ◽  
Cardiovascular Risk ◽  
Cardiovascular Diseases ◽  
Cause Of Death ◽  
Computer Assisted ◽  
Funding Source ◽  
Cvd Risk ◽  
Private Company ◽  
Men And Women

Abstract Background Recent reports evidenced gender differences in the knowledge, perception and awareness of cardiovascular risk factors and cardiovascular diseases. Purposes To evaluate trends in awareness of cardiovascular risk, as well as knowledge of symptoms and preventive behaviors related to cardiovascular disease (CVD). Methods As part of Vivi con il Cuore (campaign with the goal of raising awareness about women's heart disease) a nationwide survey was conducted. Standardized questions on awareness of CVD risk, as well as prevention behaviors and barriers, were provided through a computer-assisted web interviewing platform to a large sample of Italians citizens ranging from 40 to 70 years old. The sample was representative of the population by age, sex, and area of geographical residence. Results A total of 1,000 subjects were included in this survey, of which 511 (51%) female. About 60% of women indicated cancer as the leading cause of death among female sex, while only 22% indicated cardiovascular disease. Similarly, when the same question was asked to men, 44% indicated cancer and 21% cardiovascular disease, observations that were consistent across age categories. Although a well sizable part of the population (90% of the interviewees) have consulted the general practitioner in the last year, only 45% of women and 56% of men declared to receive information about CVD risk. Almost 84% among men and women, recognized the importance of knowing how to understand the symptoms of a heart attack due to the possibility of survival. An additional survey was conducted among young cardiologists under 40 years old, including a total of 200 young cardiologists, similarly distributed among men and women (47% and 53% respectively). About 24% of young cardiologists indicated breast cancer as the leading cause of death in women, while only 70% reported cardiovascular diseases. Furthermore, 35% of participants reported that they did not have adequate training on the risks of heart disease in women. Conclusions In this survey, only 22% of women were aware that cardiovascular disease is the number one killer of women. Likewise, a well sizable part of young cardiologists (30%) does not recognize cardiovascular disease as the leading cause of death in women. These data should inform public health campaigns to focus on evidence-based strategies to prevent CVD and to help target messages that resonate and motivate women to take action. Funding Acknowledgement Type of funding source: Private company. Main funding source(s): Abbott

Subclinical Hypothyroidism as a Risk Factor for Cardiovascular Disease

2021 ◽  
Vol 15 (9) ◽  
pp. 2748-2752
Author(s):  
Roman Evgenyevich Tokmachev ◽  
Andrey Valerievich Budnevsky ◽  
Andrey Yakovlevich Kravchenko ◽  
Tatiana Alexandrovna Chernik ◽  
Sudakov Oleg Valerievich ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Risk Factor ◽  
Cardiovascular Diseases ◽  
Cause Of Death ◽  
Subclinical Hypothyroidism ◽  
Thyroid Dysfunction ◽  
Epidemiological Studies ◽  
Cardiovascular Disorders ◽  
The World

Nowadays, more than 485 million people in the world suffer from cardiovascular diseases (CVD). According to large epidemiological studies, the group of CVD is the leading cause of death in the world. One of the neurohumoral mechanisms that appears to be a risk factor for CVD is thyroid dysfunction. In this regard, in recent years, more and more attention is paid to the study the influence of subclinical hypothyroidism on the occurrence and development of cardiovascular disorders. MeSH words: cardiovascular diseases, subclinical hypothyroidism

scholarly journals Sudden cardiac death rates in an Australian population: a data linkage study

2015 ◽  
Vol 39 (5) ◽  
pp. 561 ◽  
Author(s):  
Jia-Li Feng ◽  
Siobhan Hickling ◽  
Lee Nedkoff ◽  
Matthew Knuiman ◽  
Christopher Semsarian ◽  
...  
Keyword(s):  
Public Health ◽  
Cardiovascular Disease ◽  
Heart Disease ◽  
Sudden Cardiac Death ◽  
Cause Of Death ◽  
Cardiac Death ◽  
Linkage Study ◽  
Mortality Data ◽  
Prevention Measures ◽  
Hospital Morbidity

Objective The aim of the present study was to develop criteria to identify sudden cardiac death (SCD) and estimate population rates of SCD using administrative mortality and hospital morbidity records in Western Australia. Methods Four criteria were developed using place, death within 24 h, principal and secondary diagnoses, underlying and associated cause of death, and/or occurrence of a post mortem to identify SCD. Average crude, age-standardised and age-specific rates of SCD were estimated using population person-linked administrative data. Results In all, 9567 probable SCDs were identified between 1997 and 2010, with one-third aged ≥35 years having no prior admission for cardiovascular disease. SCD was more frequent in men (62.1%). The estimated average annual crude SCD rate for the period was 34.6 per 100 000 person-years with an average annual age-standardised rate of 37.8 per 100 000 person-years. Age-specific standardised rates were 1.1 per 100 000 person-years and 70.7 per 100 000 person-years in people aged 1–34 and ≥35 years, respectively. Ischaemic heart disease (IHD) was recorded as the underlying cause of death in approximately 80% of patients aged ≥35 years, followed by valvular heart disease and heart failure. IHD was the most common cause of death in those aged 1–34 years, followed by unspecified cardiomyopathy and dysrhythmias. Conclusions Administrative morbidity and mortality data can be used to estimate rates of SCD and therefore provide a suitable methodology for monitoring SCD over time. The findings highlight the magnitude of SCD and its potential for public health prevention. What is known about the topic? There is considerable variability in rates of SCD worldwide. Different data sources and varied methods of case ascertainment likely contribute to this variation. What does this paper add? The rate of SCD in Australia is low compared with international estimates from USA, Ireland, Netherlands and China. Two in every three cases of SCD aged ≥35 years had a hospitalisation history of cardiovascular disease, highlighting the opportunity for prevention. What are the implications for practitioners? High-quality person-linked administrative hospital morbidity and registered mortality data can be used to estimate rates of SCD in the population. Understanding the magnitude and distribution of SCD is imperative for developing effective public health policy and prevention measures.

scholarly journals Cardiac rehabilitation

Curationis ◽  
1981 ◽  
Vol 4 (2) ◽  
Author(s):  
D Nieman
Keyword(s):  
South Africa ◽  
Heart Disease ◽  
Cardiac Rehabilitation ◽  
Ischaemic Heart Disease ◽  
Cause Of Death ◽  
Circulatory System ◽  
Age Group ◽  
The Republic

In the Republic of South Africa, ischaemic heart disease is the main cause of death amongst Whites in the age group 20 — 65 years. The percentage for ischaemic heart disease of all deaths from diseases of the circulatory system for Whites in the age group 25 — 34 is 63% for males and 21% for females. In the age group 35 — 44 the percentages are 77% for males and 34% for females (22, p.1025).

scholarly journals Mortality from cancer and cardiovascular diseases in the county boroughs of England and Wales classified according to the sources and hardness of their water supplies, 1958–1967

1973 ◽  
Vol 71 (2) ◽  
pp. 237-252 ◽  
Author(s):  
Percy Stocks
Keyword(s):  
Cardiovascular Disease ◽  
Nervous System ◽  
Heart Disease ◽  
Cardiovascular Diseases ◽  
England And Wales ◽  
Average Hardness ◽  
Female Breast ◽  
Total Cancer ◽  
Artesian Wells ◽  
Rheumatic Heart

SUMMARYRelative rates of proportionate mortality from cancer of six sites based on total cancer deaths and the proportions expected in all towns, and from four types of cardiovascular disease based on total deaths from all causes, have been related in the 80 county boroughs of England and Wales to the sources of water supply and to the average hardness of water in. the towns. The sources of water, from upland surfaces, artesian wells and rivers, were classified in eight groups, and significant associations were found for cancers of the stomach, oesophagus, prostate, male bladder and female breast, and for hypertensive and chronic rheumatic heart disease. No associations were apparent with intestinal cancer, vascular disease of the nervous system or arteriosclerotic heart disease. Hardness or softness of the water was classified in seven groups and significant associations were found for the same diseases as for source of water, none being evident for coronary disease.

scholarly journals A modern view of the place of b-blockers in the treatmentof cardiovascular disease: the choice of drug within a class is crucial

2015 ◽  
Vol 12 (4) ◽  
pp. 69-74
Author(s):  
O D Ostroumova ◽  
V M Fomina ◽  
E A Smolyarchuk
Keyword(s):  
Heart Failure ◽  
Cardiovascular Disease ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Cardiovascular Diseases ◽  
Chronic Heart Failure ◽  
Arterial Hypertension ◽  
Clinical Studies ◽  
Metoprolol Succinate ◽  
Selection Of

In the article discusses questions of application of b-blockers (b-AB) for the treatment of arterial hypertension, coronary heart disease, chronic heart failure. The data from modern Russian and European recommendations about the place of b-AB in the treatment of cardiovascular diseases. Analyzed in detail the selection of b-AB inside the class from the standpoint of pharmacokinetics, selectivity, study in clinical studies. Data about efficiency and safety of application of metoprolol succinate for the treatment of arterial hypertension, coronary heart disease, chronic heart failure.

scholarly journals Coronary Heart Disease

2021 ◽  
Vol 03 (02) ◽  
pp. 31-36
Author(s):  
Ishankulova Nasiba Nurmamadovna ◽  
Keyword(s):  
Cardiovascular Disease ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Literature Review ◽  
Cause Of Death ◽  
Clinical Picture

The article covers the etiology, pathogenesis, classification, diagnosis, clinical picture and treatment of coronary heart disease, provides a literature review. Cardiovascular disease (CVD) represents the leading cause of death among women as well as men. The number of deaths due to CVD in women are greater than in men. There are significant gender-related differences concerning CVD.

scholarly journals Time Trends in Cardiovascular Disease Mortality Across the BRICS

Circulation ◽  
2020 ◽  
Vol 141 (10) ◽  
pp. 790-799 ◽  
Author(s):  
Zhiyong Zou ◽  
Karly Cini ◽  
Bin Dong ◽  
Yinghua Ma ◽  
Jun Ma ◽  
...  
Keyword(s):  
South Africa ◽  
Cardiovascular Disease ◽  
Heart Disease ◽  
Mortality Rate ◽  
Annual Percentage Change ◽  
Birth Cohorts ◽  
Period Effects ◽  
Standardized Mortality Rate ◽  
Over Time ◽  
Cvd Mortality

Background: Brazil, Russia, India, China, and South Africa (BRICS) are emerging economies making up almost half the global population. We analyzed trends in cardiovascular disease (CVD) mortality across the BRICS and associations with age, period, and birth cohort. Methods: Mortality estimates were derived from the Global Burden of Disease Study 2017. We used age-period-cohort modeling to estimate cohort and period effects in CVD between 1992 and 2016. Period was defined as survey year, and period effects reflect population-wide exposure at a circumscribed point in time. Cohort effects are defined as differences in risks across birth cohort. Net drift (overall annual percentage change), local drift (annual percentage change in each age group), longitudinal age curves (expected longitudinal age-specific rate), and period (cohort) relative risks were calculated. Results: In 2016, there were 8.4 million CVD deaths across the BRICS. Between 1992 and 2016, the reduction in CVD age-standardized mortality rate in BRICS (−17%) was less than in North America (−39%). Eighty-eight percent of the increased number of all-cause deaths resulted from the increase in CVD deaths. The age-standardized mortality rate from stroke and hypertensive heart disease declined by approximately one-third across the BRICS, whereas ischemic heart disease increased slightly (2%). Brazil had the largest age-standardized mortality rate reductions across all CVD categories, with improvement both over time and in recent birth cohorts. South Africa was the only country where the CVD age-standardized mortality rate increased. Different age-related CVD mortality was seen in those ≥50 years of age in China, ≤40 years of age in Russia, 35 to 60 years of age in India, and ≥55 years of age in South Africa. Improving period and cohort risks for CVD mortality were generally found across countries, except for worsening period effects in India and greater risks for ischemic heart disease in Chinese cohorts born in the 1950s and 1960s. Conclusions: Except for Brazil, reductions of CVD mortality across the BRICS have been less than that in North America, such that China, India, and South Africa contribute an increasing proportion of global CVD deaths. Brazil’s example suggests that prevention policies can both reduce the risks for younger birth cohorts and shift the risks for all age groups over time.

Psychophysiological Rationale for Use of Yoga in Heart Disease

2018 ◽  
pp. 203-217
Author(s):  
Subhash Manchanda ◽  
Kushal Madan
Keyword(s):  
Developing Countries ◽  
Heart Disease ◽  
Cardiovascular Diseases ◽  
Secondary Prevention ◽  
Cause Of Death ◽  
Economic Burden ◽  
Cost Effective ◽  
Unhealthy Lifestyle ◽  
Safe Strategy ◽  
Lack Of Exercise

Cardiovascular diseases (CVD) are the leading cause of death and disability worldwide. The main reason for increase of CVD is considered to be unhealthy lifestyle consistent of high fat, refined diet, psychosocial stress, lack of exercise and tobacco. In spite of several recent advances in the management of CVD the incidence is rapidly increasing specially in the developing countries and their economic burden is huge. There is a need for new cost effective and safe strategy to control this growing epidemic of CVD. Yoga may be such an alternative for controlling CVD. Several research studies suggest that yoga may be promising technique for primary and secondary prevention of CVD and these will be reviewed briefly in this chapter.

scholarly journals Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

2016 ◽  
Vol 2016 ◽  
pp. 1-12 ◽  
Author(s):  
Stella Bernardi ◽  
Fleur Bossi ◽  
Barbara Toffoli ◽  
Bruno Fabris
Keyword(s):  
Cardiovascular Disease ◽  
Decision Making ◽  
Cardiovascular Diseases ◽  
Cause Of Death ◽  
Clinical Decision Making ◽  
Clinical Decision ◽  
Clinical Applications ◽  
Nuclear Factor ◽  
Potential Utility ◽  
Receptor Activator

Cardiovascular diseases (CVD) remain the major cause of death and premature disability in Western societies. Assessing the risk of CVD is an important aspect in clinical decision-making. Among the growing number of molecules that are studied for their potential utility as CVD biomarkers, a lot of attention has been focused on osteoprotegerin (OPG) and its ligands, which are receptor activator of nuclear factorκB ligand (RANKL) and TNF-related apoptosis-inducing ligand. Based on the existing literature and on our experience in this field, here we review what the possible roles of OPG and TRAIL in CVD are and their potential utility as CVD biomarkers.

Sign in / Sign up

Export Citation Format

Share Document